Literature DB >> 20594199

Magnetic resonance imaging cannot predict histological tumour involvement of a circumferential surgical margin in rectal cancer.

O F Dent1, P H Chapuis, N Haboubi, L Bokey.   

Abstract

AIM: Several recent studies have attempted to evaluate the accuracy of preoperative magnetic resonance imaging (MRI) in predicting the likelihood of tumour involvement of the postoperative circumferential resection margin (CRM) in rectal cancer with the intention of selecting patients who might benefit from neoadjuvant therapy and as a guide to surgery. The aim of this study was to assess whether such studies can provide a valid answer as to whether preoperative MRI can accurately predict CRM involvement by tumour.
METHOD: The study design and methodology of studies on this topic were critically examined.
RESULTS: Features identified as affecting the efficacy of these studies were: representativeness of patients, definition of the margin assessed by MRI and by histology, lack of blinding of surgeons and pathologists to MRI results, effect of neoadjuvant treatment, and number of patients studied.
CONCLUSION: Because of methodological inadequacies in studies completed to date, there is insufficient evidence of the ability of a positive MRI result to predict an involved CRM. Although MRI may be able to identify a tumour that has extended to the mesorectal fascia and/or intersphincteric plane, logically, it cannot indicate where the surgical boundary of the resection will ultimately lie, and therefore cannot validly predict an involved CRM and should not be relied upon for this purpose.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2010        PMID: 20594199     DOI: 10.1111/j.1463-1318.2010.02358.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it?

Authors:  M L Sautter-Bihl; W Hohenberger; R Fietkau; C Rödel; H Schmidberger; R Sauer
Journal:  Strahlenther Onkol       Date:  2013-02       Impact factor: 3.621

Review 2.  Intersphincteric resection for very low rectal cancer: a systematic review.

Authors:  Yoshito Akagi; Tetsushi Kinugasa; Kazuo Shirouzu
Journal:  Surg Today       Date:  2012-11-09       Impact factor: 2.549

3.  Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.

Authors:  Changhoon Song; Sanghyuk Song; Jae-Sung Kim; Heung-Kwon Oh; Duck-Woo Kim; Keun-Wook Lee; Jee Hyun Kim; Keun-Yong Eom; In Ah Kim; Sung-Bum Kang
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

4.  Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer.

Authors:  Jochen Gaedcke; Andreas Leha; Rainer Claus; Dieter Weichenhan; Klaus Jung; Julia Kitz; Marian Grade; Hendrik A Wolff; Peter Jo; Jérôme Doyen; Jean-Pierre Gérard; Steven A Johnsen; Christoph Plass; Tim Beißbarth; Michael Ghadimi
Journal:  Oncotarget       Date:  2014-09-30

Review 5.  Intersphincteric resection for very low rectal cancer: A review of the updated literature.

Authors:  Kazuo Shirouzu; Naotaka Murakami; Yoshito Akagi
Journal:  Ann Gastroenterol Surg       Date:  2017-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.